The Value of PET Imaging Targeting Granzyme B in Predicting Efficacy and Prognosis in T-NK Cell Lymphoma
Not yet recruitingOBSERVATIONAL
Enrollment
50
Participants
Timeline
Start Date
March 1, 2025
Primary Completion Date
December 31, 2029
Study Completion Date
December 31, 2029
Conditions
T-NK Cell Lymphoma
Trial Locations (1)
Unknown
Ruijin Hospital Affiliated to Shanghai Jiao Tong University Medical School, Shanghai, Shanghai
All Listed Sponsors
lead
Ruijin Hospital
OTHER
NCT06863441 - The Value of PET Imaging Targeting Granzyme B in Predicting Efficacy and Prognosis in T-NK Cell Lymphoma | Biotech Hunter | Biotech Hunter